KalVista Pharmaceuticals
KALV
KALV
68 hedge funds and large institutions have $398M invested in KalVista Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
+11
Holders Change %
+19.3%
% of All Funds
1.47%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.15%
New
17
Increased
20
Reduced
16
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
PC
Polar Capital
London,
United Kingdom
|
+$30.6M |
2 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$21M |
3 |
Millennium Management
New York
|
+$2.76M |
4 |
O
OrbiMed
New York
|
+$2.59M |
5 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
+$1.86M |
Top Sellers
1 |
SHI
SV Health Investors
Boston,
Massachusetts
|
-$20.5M |
2 |
VMI
VHCP Management III
New York
|
-$9M |
3 |
VMI
VHCP Management II
New York
|
-$5.31M |
4 |
BI
BVF Inc
San Francisco,
California
|
-$4.99M |
5 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$3.03M |